Classes
Publications
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy2015 | First Faculty of Medicine
- Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: Data from the MedPed CZ database and the Czech population2011 | First Faculty of Medicine
- Dyslipidemia and obesity 2011. How are related and what is different2011 | First Faculty of Medicine
- Interaction of common sequence variants and selected risk factors in determination of HDL cholesterol levels.2010 | First Faculty of Medicine
- Hyperlipoproteinaemia and dyslipoproteinaemia 1. Classification, diagnostics, cardiovascular, cardiometabolic, residual risk2010 | First Faculty of Medicine
- Fibrates in the treatment of diabetic dyslipidemia2010 | First Faculty of Medicine
- Rosiglitazone and fenofibrate improve HDL metabolism assessed by FERHDLPublication without faculty affiliation
- Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study2024 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
- Statement CSAT on Consensus statement of the European Atherosclerosis Society: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
Loading network view...